AgomAb Therapeutics garners $74m Series B
Drug developer AgomAb Therapeutics has secured $74 million in Series B financing.
Drug developer AgomAb Therapeutics has secured $74 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination